Dagga firm Cilo Cybin prepares for clinical trials in SA as it again eyes JSE listing

Cilo Cybin Pharmaceutical may list on the JSE within months, while it is also planning to start clinical trials of cannabis-derived drugs before the end of 2023, in partnership with its new shareholder.

Related Keywords

Malaysia ,Malaysian , ,Cybin Pharmaceutical ,Cilo Cybin ,Drugs ,